Cited by 106Cancer-related Molecular PathwaysCancer and biochemical researchRedox biology and oxidative stress

Manganese Superoxide Dismutase Is a p53 -Regulated Gene That Switches Cancers between Early and Advanced Stages

Open access
Dhar, Sanjit K., Tangpong, Jitbanjong, Chaiswing, Luksana, Oberley, Terry D., St. Clair, Daret K.·2011·Cancer Research

Published version of a preprint

Abstract

Manganese superoxide dismutase (MnSOD) plays a critical role in the survival of aerobic life, and its aberrant expression has been implicated in carcinogenesis and tumor resistance to therapy. However, despite extensive studies in MnSOD regulation and its role in cancer, when and how the alteration of MnSOD expression occurs during the process of tumor development in vivo are unknown. Here, we generated transgenic mice expressing a luciferase reporter gene under the control of human MnSOD promoter-enhancer elements and investigated the changes of MnSOD transcription using the 7,12-dimethylbenz(α)anthracene (DMBA)/12-O-tetradecanoylphorbol-l3-acetate (TPA) multistage skin carcinogenesis model. The results show that MnSOD expression was suppressed at a very early stage but increased at late stages of skin carcinogenesis. The suppression and subsequent restoration of MnSOD expression were mediated by two transcription-factors, Sp1 and p53. Exposure to DMBA and TPA activated p53 and decreased MnSOD expression via p53-mediated suppression of Sp1 binding to the MnSOD promoter in normal-appearing skin and benign papillomas. In squamous cell carcinomas, Sp1 binding increased because of the loss of functional p53. We used chromatin immunoprecipitation, electrophoretic mobility shift assay, and both knockdown and overexpression of Sp1 and p53 to verify their roles in the expression of MnSOD at each stage of cancer development. The results identify MnSOD as a p53-regulated gene that switches between early and advanced stages of cancer. These findings also provide strong support for the development of means to reactivate p53 for the prevention of tumor progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-1233

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Dhar, S. K., Tangpong, J., Chaiswing, L., Oberley, T. D., & St. Clair, D. K.
Affiliations
  • University of Wisconsin–Madison (US)
  • Authors' Affiliations: 1Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky; and 2Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Venue
Cancer Research
Published
2011-10-30
Volume
71
Issue
21
Pages
6684-6695
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2161465168
Cited by
106
References
45
Citations by year
2026: 1 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 10 · 2016: 6 · 2015: 10 · 2014: 8 · 2013: 15 · 2012: 8
FWCI
5.05
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (CA 73599, R01CA073599, CA49797, R01CA049797)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
manganese superoxide dismutase, p53, Sp1, transcriptional regulation, skin carcinogenesis, squamous cell carcinoma, tumor progression, p53 reactivation, transcription factor binding
MeSH terms
Animals, Carcinogens, Carcinoma, Squamous Cell, Cocarcinogenesis, Enhancer Elements, Genetic, Female, Genes, Synthetic, Humans, Mice, Transgenic, Neoplasm Proteins, Papilloma, Promoter Regions, Genetic, Recombinant Fusion Proteins, Skin Neoplasms, Superoxide Dismutase, Tetradecanoylphorbol Acetate, Transcription, Genetic, 9,10-Dimethyl-1,2-benzanthracene, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Sp1 Transcription Factor, Genes, Reporter, Disease Progression, Mice, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review